Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) has a profit margin of -5572.45%, below the Consumer Discretionary sector average of 10.39%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for ZIVOW is -5572.45% as of March 2026. That compares with -13430.07% in the prior-year period — up 58.5% year over year. That is below the Consumer Discretionary sector average of 10.39%. Investors often review this figure alongside Zivo Bioscience- Warrants (29/04/2026)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, ZIVOW's profit margin moved from -13430.07% to -5572.45% — a 58.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zivo Bioscience- Warrants (29/04/2026)'s valuation or profitability profile.
Against Consumer Discretionary companies, ZIVOW currently prints -5572.45% for profit margin, while the sector average sits near 10.39%. That is roughly 53708.2% below the sector mean. Large gaps often invite a closer look at Zivo Bioscience- Warrants (29/04/2026)'s growth, margins, and balance sheet.
Profit Margin shows how effectively Zivo Bioscience- Warrants (29/04/2026) converts resources into returns. At -5572.45%, ZIVOW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -13430.07% in the prior-year period — up 58.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ZIVOW's profit margin (-5572.45%), review year-over-year change from -13430.07%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.